Immunosuppressive drugs in organ transplant recipients--rationale for critical selection

Stucker, Fabien; Marti, Hans-Peter; Hunger, Robert E (2012). Immunosuppressive drugs in organ transplant recipients--rationale for critical selection. Current problems in dermatology, 43, pp. 36-48. Basel: Karger

Full text not available from this repository. (Request a copy)

Transplantation is the treatment of choice for many different organ failures. Despite growing experience in surgery and immunosuppression protocols, the long-term mortality of the procedure remains much higher than in the general population. Second only to cardiovascular diseases as the cause of death in organ transplant recipients, cancer is now known to be at least partly related to the immunosuppression regimen. Nevertheless, if calcineurin inhibitors have a demonstrated pro-oncogenic effect, other classes, such as mTOR inhibitors, are antiproliferative, and even demonstrated as an efficient therapy in some advanced oncological situations. Therefore, the adaptation of the therapy protocol evolves now towards an individualized medicine based on the risk factors of each transplant recipient in terms of cardiovascular, infectious and oncological diseases. As the first organ involved by tumor is the skin, many different guidelines have been published to try and adapt the therapy to the occurrence of a new lesion. If, for example, limited actinic keratosis or the first episode of a non-melanoma skin cancer usually requires no change of the immunosuppressive therapy, but a local specialized care and frequent clinical controls, more advanced lesions imply the adaptation of the drug regimen. In any case, the collaboration between general practitioners, dermatologists and the transplantation team is mandatory.

Item Type:

Journal Article (Further Contribution)


04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology

UniBE Contributor:

Hunger, Robert








Factscience Import

Date Deposited:

04 Oct 2013 14:38

Last Modified:

26 Mar 2018 14:33

PubMed ID:


URI: (FactScience: 222839)

Actions (login required)

Edit item Edit item
Provide Feedback